Cargando…
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261710/ http://dx.doi.org/10.1186/1750-9378-4-S2-O12 |
| _version_ | 1782348311427022848 |
|---|---|
| author | Gasperini, P Tosato, G |
| author_facet | Gasperini, P Tosato, G |
| author_sort | Gasperini, P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4261710 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42617102014-12-10 Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses Gasperini, P Tosato, G Infect Agent Cancer Oral Presentation BioMed Central 2009-06-17 /pmc/articles/PMC4261710/ http://dx.doi.org/10.1186/1750-9378-4-S2-O12 Text en Copyright © 2009 Gasperini and Tosato; licensee BioMed Central Ltd. |
| spellingShingle | Oral Presentation Gasperini, P Tosato, G Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses |
| title | Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses |
| title_full | Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses |
| title_fullStr | Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses |
| title_full_unstemmed | Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses |
| title_short | Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses |
| title_sort | rapamycin reduces primary effusion lymphoma progression by targeting vegf production and vegf responses |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261710/ http://dx.doi.org/10.1186/1750-9378-4-S2-O12 |
| work_keys_str_mv | AT gasperinip rapamycinreducesprimaryeffusionlymphomaprogressionbytargetingvegfproductionandvegfresponses AT tosatog rapamycinreducesprimaryeffusionlymphomaprogressionbytargetingvegfproductionandvegfresponses |